{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:06:31Z","timestamp":1790179591075,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009702","name":"Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009702","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","thrombosisresearch.com","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.thromres.2024.109151","type":"journal-article","created":{"date-parts":[[2024,9,13]],"date-time":"2024-09-13T06:48:53Z","timestamp":1726210133000},"page":"109151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura"],"prefix":"10.1016","volume":"243","author":[{"given":"Addolorata","family":"Truma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Agosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Artoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri Alessandro","family":"Giannotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualina","family":"De Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flora","family":"Peyvandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.thromres.2024.109151_bb0005","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1002\/pbc.24612","article-title":"Children and adults with thrombotic thrombocytopenic purpura associated with severe, acquired Adamts13 deficiency: comparison of incidence, demographic and clinical features","volume":"60","author":"Reese","year":"2013","journal-title":"Pediatr. Blood Cancer"},{"issue":"7","key":"10.1016\/j.thromres.2024.109151_bb0010","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J. Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109151_bb0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/01.ede.0000113273.14807.53","article-title":"Incidence of thrombotic thrombocytopenic purpura\/hemolytic uremic syndrome","volume":"15","author":"Miller","year":"2004","journal-title":"Epidemiology"},{"issue":"5","key":"10.1016\/j.thromres.2024.109151_bb0020","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1111\/j.1365-2141.2008.07276.x","article-title":"Regional UK TTP Registry: correlation with laboratory ADAMTS 13 analysis and clinical features","volume":"142","author":"Scully","year":"2008","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2024.109151_bb0025","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1016\/S2352-3026(16)30018-7","article-title":"Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy","volume":"3","author":"Mariotte","year":"2016","journal-title":"Lancet Haematol."},{"issue":"8","key":"10.1016\/j.thromres.2024.109151_bb0030","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1182\/blood-2009-09-243790","article-title":"Survival and relapse in patients with thrombotic thrombocytopenic purpura","volume":"115","author":"Hovinga","year":"2010","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.thromres.2024.109151_bb0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/imj.12935","article-title":"Diagnosis and management of thrombotic thrombocytopenic purpura (TTP) in Australia: findings from the first 5 years of the Australian TTP\/thrombotic microangiopathy registry","volume":"46","author":"Blombery","year":"2016","journal-title":"Intern. Med. J."},{"issue":"5","key":"10.1016\/j.thromres.2024.109151_bb0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1111\/bjh.13658","article-title":"Impact of severe ADAMTS13 deficiency on clinical presentation and outcomes in patients with thrombotic microangiopathies: the experience of the Harvard TMA Research Collaborative","volume":"171","author":"Bendapudi","year":"2015","journal-title":"Br. J. Haematol."},{"issue":"5","key":"10.1016\/j.thromres.2024.109151_bb0045","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1055\/s-0039-1679907","article-title":"Clinical and laboratory features of patients with acquired thrombotic thrombocytopenic purpura: fourteen years of the Milan TTP Registry","volume":"119","author":"Mancini","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2024.109151_bb0050","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s11684-016-0492-5","article-title":"Diagnosis and management of acquired thrombotic thrombocytopenic purpura in Southeast China: a single center experience of 60 cases","volume":"10","author":"Zhou","year":"2016","journal-title":"Front. Med."},{"issue":"10","key":"10.1016\/j.thromres.2024.109151_bb0055","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1182\/bloodadvances.2017005124","article-title":"Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015","volume":"1","author":"Page","year":"2017","journal-title":"Blood Adv."},{"issue":"5","key":"10.1016\/j.thromres.2024.109151_bb0060","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1111\/bjh.17126","article-title":"Cerebral MRI findings predict the risk of cognitive impairment in thrombotic thrombocytopenic purpura","volume":"191","author":"Alwan","year":"2020","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2024.109151_bb0065","series-title":"Brain Lesions Are most Often Reversible in Acute Thrombotic Thrombocytopenic Purpura","author":"Burrus","year":"2009"},{"issue":"11","key":"10.1016\/j.thromres.2024.109151_bb0070","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1016\/j.jstrokecerebrovasdis.2018.07.017","article-title":"Immune-thrombotic thrombocytopenic purpura is a rare cause of ischemic stroke in young adults: case reports and literature review","volume":"27","author":"Tomich","year":"2018","journal-title":"J. Stroke Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2024.109151_bb0075","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1159\/000513574","article-title":"Identification of biomarkers in patients with thrombotic thrombocytopenic purpura presenting with large and small ischemic stroke","volume":"11","author":"Lin","year":"2021","journal-title":"Cerebrovasc. Dis. Extra."},{"issue":"10","key":"10.1016\/j.thromres.2024.109151_bb0080","doi-asserted-by":"crossref","first-page":"5023","DOI":"10.1007\/s00415-023-11830-y","article-title":"Predictors of acute ischemic cerebral lesions in immune-mediated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome","volume":"270","author":"Neuman","year":"2023","journal-title":"J. Neurol."},{"issue":"01","key":"10.1016\/j.thromres.2024.109151_bb0085","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1055\/s-0040-1722610","article-title":"Cerebral infarction in immune thrombotic thrombocytopenic purpura is associated with old age, hypertension, smoking, and anti-ADAMTS13 Ig, but not with mortality","volume":"05","author":"Memon","year":"2021","journal-title":"TH Open."},{"issue":"08","key":"10.1016\/j.thromres.2024.109151_bb0090","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1160\/TH13-08-0688","article-title":"FRETS-VWF73 rather than CBA assay reflects ADAMTS13 proteolytic activity in acquired thrombotic thrombocytopenic purpura patients","volume":"112","author":"Mancini","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"11","key":"10.1016\/j.thromres.2024.109151_bb0095","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1055\/s-0039-1696718","article-title":"Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS13 activity","volume":"119","author":"Valsecchi","year":"2019","journal-title":"Thromb. Haemost."},{"issue":"2","key":"10.1016\/j.thromres.2024.109151_bb0100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.11739","article-title":"ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission","volume":"93","author":"Peyvandi","year":"2008","journal-title":"Haematologica"},{"issue":"8","key":"10.1016\/j.thromres.2024.109151_bb0105","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/j.1538-7836.2012.04808.x","article-title":"ADAMTS-13 activity and autoantibodies classes and subclasses as prognostic predictors in acquired thrombotic thrombocytopenic purpura","volume":"10","author":"Bettoni","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2024.109151_bb0110","article-title":"Large vessel stroke as initial presentation of thrombotic thrombocytopenic purpura","volume":"2018","author":"Sugarman","year":"2018","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.thromres.2024.109151_bb0115","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1161\/01.STR.22.8.1087","article-title":"Stroke in relapsing thrombotic thrombocytopenic purpura","volume":"22","author":"Rinkel","year":"1991","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2024.109151_bb0120","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1161\/01.STR.25.6.1297","article-title":"Silent brain infarct in thrombotic thrombocytopenic purpura","volume":"25","author":"Wijdicks","year":"1994","journal-title":"Stroke"},{"key":"10.1016\/j.thromres.2024.109151_bb0125","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1212\/WNL.50.4.1157","article-title":"Middle cerebral artery main stem thrombosis in two siblings with familial thrombotic thrombocytopenic purpura","volume":"50","author":"Kelly","year":"1998","journal-title":"Neurology"},{"key":"10.1016\/j.thromres.2024.109151_bb0130","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1159\/000078756","article-title":"Major stroke in thromboticthrombocytopenic purpura (Moschcowitz syndrome)","volume":"18","author":"Scheid","year":"2004","journal-title":"Cerebrovasc. Dis."},{"issue":"1","key":"10.1016\/j.thromres.2024.109151_bb0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12883-023-03073-1","article-title":"Two ischemic stroke events within 48 h: a case report of an unusual presentation of thrombotic thrombocytopenic purpura","volume":"23","author":"Jameie","year":"2023","journal-title":"BMC Neurol."},{"issue":"9","key":"10.1016\/j.thromres.2024.109151_bb0140","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272290","article-title":"Neurological manifestations in thrombotic microangiopathy: imaging features, risk factors and clinical course","volume":"17","author":"De Castro","year":"2022","journal-title":"PLoS One"},{"issue":"4","key":"10.1016\/j.thromres.2024.109151_bb0145","first-page":"555","article-title":"Posterior reversible encephalopathy syndrome in thrombotic thrombocytopenic purpura","volume":"5","author":"Bhat","year":"2020","journal-title":"Ann. Indian Acad. Neurol."},{"issue":"7","key":"10.1016\/j.thromres.2024.109151_bb0150","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/archneurol.2010.119","article-title":"Renal failure and posterior reversible encephalopathy syndrome in patients with thrombotic thrombocytopenic purpura","volume":"67","author":"Burrus","year":"2010","journal-title":"Arch. Neurol."},{"issue":"11","key":"10.1016\/j.thromres.2024.109151_bb0155","first-page":"1652","article-title":"Thrombotic thrombocytopenic purpura presenting with reversible posterior leukoencephalopathy syndrome","volume":"50","author":"Aota","year":"2009","journal-title":"Rinsho Ketsueki"},{"issue":"49","key":"10.1016\/j.thromres.2024.109151_bb0160","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000031851","article-title":"Thrombotic thrombocytopenic purpura with neurological impairment: a review","volume":"101","author":"Zhu","year":"2022","journal-title":"Medicine (Baltimore)"}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002834?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384824002834?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,19]],"date-time":"2024-09-19T02:41:46Z","timestamp":1726713706000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384824002834"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":32,"alternative-id":["S0049384824002834"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109151","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Main features of ischemic stroke in patients with acute immune-mediated thrombotic thrombocytopenic purpura","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2024.109151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109151"}}